HSCS vs. SSKN, CTCX, QTI, ALUR, BTCY, AEMD, CHEK, ICU, POAI, and NURO
Should you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include STRATA Skin Sciences (SSKN), Carmell (CTCX), QT Imaging (QTI), Allurion Technologies (ALUR), Biotricity (BTCY), Aethlon Medical (AEMD), Check-Cap (CHEK), SeaStar Medical (ICU), Predictive Oncology (POAI), and NeuroMetrix (NURO). These companies are all part of the "medical equipment" industry.
Heart Test Laboratories vs.
STRATA Skin Sciences (NASDAQ:SSKN) and Heart Test Laboratories (NASDAQ:HSCS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation, earnings and community ranking.
32.4% of STRATA Skin Sciences shares are owned by institutional investors. Comparatively, 17.2% of Heart Test Laboratories shares are owned by institutional investors. 39.0% of STRATA Skin Sciences shares are owned by company insiders. Comparatively, 1.8% of Heart Test Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Heart Test Laboratories has lower revenue, but higher earnings than STRATA Skin Sciences. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Heart Test Laboratories, indicating that it is currently the more affordable of the two stocks.
Heart Test Laboratories has a consensus target price of $13.50, suggesting a potential upside of 286.71%. Given Heart Test Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Heart Test Laboratories is more favorable than STRATA Skin Sciences.
Heart Test Laboratories has a net margin of 0.00% compared to STRATA Skin Sciences' net margin of -28.72%. STRATA Skin Sciences' return on equity of -69.33% beat Heart Test Laboratories' return on equity.
STRATA Skin Sciences has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Comparatively, Heart Test Laboratories has a beta of 2.9, suggesting that its share price is 190% more volatile than the S&P 500.
STRATA Skin Sciences received 218 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 83.33% of users gave Heart Test Laboratories an outperform vote while only 63.90% of users gave STRATA Skin Sciences an outperform vote.
In the previous week, Heart Test Laboratories had 2 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 2 mentions for Heart Test Laboratories and 0 mentions for STRATA Skin Sciences. STRATA Skin Sciences' average media sentiment score of 0.00 equaled Heart Test Laboratories'average media sentiment score.
Summary
Heart Test Laboratories beats STRATA Skin Sciences on 10 of the 17 factors compared between the two stocks.
Get Heart Test Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Heart Test Laboratories Competitors List
Related Companies and Tools
This page (NASDAQ:HSCS) was last updated on 1/21/2025 by MarketBeat.com Staff
